NCT03847389View on ClinicalTrials.gov

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

May 2, 2020

Study Completion Date

July 28, 2020

Conditions
Atopic Dermatitis
Interventions
DRUG

Clobetasol propionate 0.05% Topical Oil

thin film application of the oil twice daily

Trial Locations (6)

19103

Paddington Testing Co., Inc., Philadelphia

23220

Clinical Research Partners, LLC, Richmond

29303

Spartanburg Medical Research, Spartanburg

31406

AeroAllergy Research Laboratories of Savannah, Inc, Savannah

32771

International Clinical Research - US, LLC, Sanford

78213

Progressive Clinical Research, San Antonio

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Synteract, Inc.

INDUSTRY

collaborator

Covance

INDUSTRY

lead

Hill Dermaceuticals, Inc.

INDUSTRY

NCT03847389 - Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter